Intrinsic Value of S&P & Nasdaq Contact Us

Neogen Corporation NEOG NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
$2.63
-72.6%
Analyst Price Target
$11.00
+14.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Neogen Corporation (NEOG) has a negative trailing P/E of -3.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 26.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -26.49%, forward earnings yield 3.72%. PEG 5.07.

Criteria proven by this page:

  • VALUE (56/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 26.9 — analysts expect a return to profitability with estimated EPS of $0.36 for FY2026.
  • PEG Ratio 5.07 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -26.49% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 3.72% as earnings recover.
  • Analyst consensus target $11.00 (+14.5% upside) — modest upside expected.

Overall SharesGrow Score: 45/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
45/100
SG Score
View full scorecard →
~
VALUE
56/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
59/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NEOG

Valuation Multiples
P/E (TTM)-3.8
Forward P/E26.9
PEG Ratio5.07
Forward PEG5.07
P/B Ratio1.09
P/S Ratio2.64
EV/EBITDA-4.5
Per Share Data
EPS (TTM)$-2.80
Forward EPS (Est.)$0.36
Book Value / Share$9.66
Revenue / Share$4.00
FCF / Share$0.03
Yields & Fair Value
Earnings Yield-26.49%
Forward Earnings Yield3.72%
Dividend Yield0.00%
SharesGrow IV$2.63 (-72.6%)
Analyst Target$11.00 (+14.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 50.7 8.63 4.59 5.77 -
2017 55.2 2.84 5.13 6.69 -
2018 62.0 1.48 6.99 9.84 -
2019 48.6 -9.88 4.58 7.06 -
2020 63.5 -36.82 5.21 9.03 -
2021 79.8 0.00 5.78 10.37 -
2022 59.0 -2.80 3.21 5.41 -
2023 -144.4 1.14 1.05 4.02 -
2024 -302.2 4.74 0.91 3.08 -
2025 -1.2 0.00 0.61 1.42 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.36 $321.28M $36.56M 11.4%
2017 $0.43 $361.59M $43.79M 12.1%
2018 $0.60 $402.25M $63.15M 15.7%
2019 $0.57 $414.19M $60.18M 14.5%
2020 $0.56 $418.17M $59.48M 14.2%
2021 $0.57 $468.46M $60.88M 13%
2022 $0.45 $527.16M $48.31M 9.2%
2023 $-0.12 $822.45M $-22.87M -2.8%
2024 $-0.04 $924.22M $-9.42M -1%
2025 $-5.03 $894.66M $-1.09B -122.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.34 $0.32 – $0.37 $850.58M $849.19M – $852.58M 3
2027 $0.33 $0.32 – $0.35 $864.75M $849.49M – $879.44M 3
2028 $0.43 $0.40 – $0.45 $873.37M $871.16M – $875.58M 2
2029 $0.47 $0.46 – $0.47 $888.15M $879.82M – $895.09M 1
2030 $0.46 $0.45 – $0.46 $869.1M $860.95M – $875.89M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message